SPDR S&P Biotech ETF Rating $80.89 +1.79 (+2.26%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsBuy This Stock SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.78Holdings in XBI have an aggregate rating of Moderate Buy based on 768 analyst ratings issued in the past year covering 50 companies (77.8% of the portfolio).XBI Aggregate Price Target$80.12-0.66% DownsideHigh Prediction$80.12Average Prediction$80.12Low Prediction$80.12Holdings in XBI have an aggregate price target of $80.12 and a range of $80.12 to $80.12 covering 50 companies (77.8% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.82%NTRANatera$154.48+4.0%2.9594 of 5 stars3.00$175.76 13.8%16Insider TradeNews CoveragePositive News2.71%VRTXVertex Pharmaceuticals$492.47+0.0%4.0215 of 5 stars2.64$514.91 4.6%25Analyst ForecastAnalyst RevisionPositive News2.70%INSMInsmed$68.96-2.6%4.176 of 5 stars3.00$94.00 36.3%16Analyst ForecastOptions VolumeNews CoveragePositive News2.66%ALNYAlnylam Pharmaceuticals$242.61+0.3%4.5951 of 5 stars2.77$315.58 30.1%26Upcoming EarningsAnalyst UpgradePositive News2.55%UTHRUnited Therapeutics$296.42+1.0%4.9305 of 5 stars2.75$395.67 33.5%12Upcoming EarningsAnalyst UpgradeInsider TradePositive News2.55%NBIXNeurocrine Biosciences$105.76+2.5%4.8567 of 5 stars2.86$161.14 52.4%22Upcoming EarningsAnalyst ForecastAnalyst Revision2.52%GILDGilead Sciences$106.15-0.2%4.5579 of 5 stars2.79$108.50 2.2%28Analyst ForecastAnalyst RevisionPositive News2.47%EXASExact Sciences$45.60+3.4%4.2635 of 5 stars2.95$69.25 51.9%22Upcoming EarningsAnalyst RevisionNews CoveragePositive News2.44%AMGNAmgen$279.84+0.7%4.6515 of 5 stars2.43$310.57 11.0%23Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News2.36%INCYIncyte$58.97+1.7%4.8409 of 5 stars2.21$74.69 26.7%19Upcoming EarningsAnalyst ForecastNews Coverage2.33%BIIBBiogen$119.51+1.1%4.7587 of 5 stars2.42$211.37 76.9%31Upcoming EarningsAnalyst Forecast2.29%MDGLMadrigal Pharmaceuticals$319.93+3.6%4.4696 of 5 stars3.00$409.00 27.8%9Analyst ForecastNews CoveragePositive News2.24%ABBVAbbVie$180.53+2.0%4.9075 of 5 stars2.85$211.19 17.0%26Upcoming EarningsAnalyst ForecastAnalyst Revision2.24%REGNRegeneron Pharmaceuticals$599.76+2.0%4.8513 of 5 stars2.88$949.60 58.3%26Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News2.14%BPMCBlueprint Medicines$86.09+0.3%2.6154 of 5 stars2.70$124.95 45.1%23Upcoming EarningsNews Coverage2.12%EXELExelixis$37.21+1.2%4.2836 of 5 stars2.50$37.59 1.0%20Upcoming EarningsPositive News1.97%BMRNBioMarin Pharmaceutical$62.74+1.3%4.8917 of 5 stars2.71$94.00 49.8%24Upcoming EarningsNews Coverage1.94%MRNAModerna$27.39+3.2%4.3506 of 5 stars2.04$58.70 114.3%24Upcoming EarningsNews Coverage1.77%TGTXTG Therapeutics$40.30+2.1%3.3821 of 5 stars2.83$40.67 0.9%6Upcoming EarningsNews CoveragePositive News1.74%BBIOBridgeBio Pharma$35.96+2.1%4.637 of 5 stars2.92$53.00 47.4%12Upcoming Earnings1.66%HALOHalozyme Therapeutics$59.25+1.4%4.4122 of 5 stars2.60$62.89 6.1%10Analyst ForecastNews CoveragePositive News1.53%RVMDRevolution Medicines$38.58+3.0%3.8818 of 5 stars3.00$66.67 72.8%12Positive News1.48%CYTKCytokinetics$40.33+6.1%3.8908 of 5 stars2.94$79.13 96.2%18Analyst ForecastInsider Trade1.44%SMMTSummit Therapeutics$36.70+10.4%1.0905 of 5 stars3.00$35.40 -3.5%10Upcoming EarningsAnalyst ForecastNews CoverageHigh Trading Volume1.40%CRSPCRISPR Therapeutics$39.11+1.5%2.9725 of 5 stars2.48$73.11 86.9%211.33%SRPTSarepta Therapeutics$61.76+3.8%4.6702 of 5 stars2.83$158.70 157.0%24Upcoming EarningsAnalyst ForecastGap Up1.28%ROIVRoivant Sciences$11.00+2.4%2.4056 of 5 stars3.00$17.50 59.1%4Analyst ForecastInsider TradeNews CoveragePositive NewsGap Up1.27%IONSIonis Pharmaceuticals$29.57+1.6%3.9444 of 5 stars2.70$56.72 91.8%20Upcoming EarningsOptions Volume1.21%ADMAADMA Biologics$22.33+2.8%1.8933 of 5 stars3.25$22.50 0.8%4News CoveragePositive News1.12%VKTXViking Therapeutics$25.66-0.5%4.2918 of 5 stars2.92$89.50 248.8%13Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap Up1.07%SWTXSpringWorks Therapeutics$44.93+9.0%2.397 of 5 stars3.00$73.20 62.9%5Upcoming EarningsNews CoveragePositive NewsHigh Trading Volume1.04%KRYSKrystal Biotech$169.12+2.0%4.7602 of 5 stars3.00$220.00 30.1%8News CoveragePositive News1.03%ALKSAlkermes$27.67+1.9%4.7878 of 5 stars2.67$38.50 39.1%12Upcoming EarningsShort Interest ↓Positive News1.03%PCVXVaxcyte$34.51+4.1%3.2661 of 5 stars3.10$136.50 295.5%10Analyst ForecastAnalyst RevisionPositive News0.98%RNAAvidity Biosciences$30.93+0.8%2.3533 of 5 stars3.00$66.69 115.6%13Positive News0.93%TWSTTwist Bioscience$40.17+6.8%3.6344 of 5 stars2.70$52.80 31.4%10Upcoming EarningsPositive News0.93%NUVLNuvalent$73.98+1.7%1.8213 of 5 stars2.90$115.50 56.1%10News CoveragePositive News0.92%ACLXArcellx$63.97+0.5%1.9024 of 5 stars3.14$110.67 73.0%14News CoveragePositive News0.91%RYTMRhythm Pharmaceuticals$62.97+5.2%3.8803 of 5 stars3.00$74.92 19.0%13News CoveragePositive NewsHigh Trading Volume0.88%VCYTVeracyte$32.14+2.1%3.9931 of 5 stars2.70$42.60 32.5%10Analyst RevisionNews CoveragePositive News0.87%SRRKScholar Rock$34.38+5.7%3.5594 of 5 stars3.00$42.67 24.1%6News CoveragePositive News0.84%RXRXRecursion Pharmaceuticals$5.75+3.0%2.3738 of 5 stars2.33$8.20 42.6%60.83%APLSApellis Pharmaceuticals$17.54+0.3%4.0858 of 5 stars2.63$45.35 158.6%19Analyst Forecast0.82%SLNOSoleno Therapeutics$74.23+2.7%4.8095 of 5 stars3.20$104.67 41.0%10Analyst ForecastPositive News0.81%RAREUltragenyx Pharmaceutical$37.64+0.9%4.4517 of 5 stars2.93$92.79 146.5%14Upcoming EarningsPositive News0.79%CRNXCrinetics Pharmaceuticals$33.39+3.2%3.5739 of 5 stars2.92$73.00 118.6%13Positive News0.75%ACADACADIA Pharmaceuticals$14.83+1.4%4.1282 of 5 stars2.50$23.93 61.4%16Positive News0.71%AKROAkero Therapeutics$40.99+3.5%4.167 of 5 stars3.00$76.29 86.1%9News CoveragePositive NewsHigh Trading Volume0.69%PTCTPTC Therapeutics$49.55-0.8%3.8549 of 5 stars2.53$63.92 29.0%15Analyst Forecast0.66%AGIOAgios Pharmaceuticals$29.26+3.1%3.8506 of 5 stars2.56$56.57 93.3%9Upcoming Earnings This page (NYSEARCA:XBI) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
